Cocaine-and amphetamine-regulated transcript modulates peripheral immunity and protects against brain injury in experimental stroke.
Ischemic stroke can induce immediate activation and later inhibition of the peripheral immune system which may contribute to a worse outcome. Cocaine-and amphetamine-regulated transcript (CART) peptides have been reported to have neuroprotective and immunomodulatory effects in various cell and animal experimental models, respectively. In this study, CART's role in experimental stroke and the relevant immune-regulating mechanisms was investigated. In male C57BL/6 mice subjected to 120 min of middle cerebral artery occlusion (MCAO), with or without CART treatment or sham operation, peripheral immune parameters and serum catecholamins (CAs) were analyzed. CART reduced blood CD4(+)/CD8(+) ratio and pro-inflammatory cytokine expression in MCAO mice at 24 h, while upregulated spleen CD4(+)/CD8(+) ratio and enhanced anti-inflammatory cytokines expressions in MCAO mice at 96 h. In addition, in comparison to control mice, CART-treated mice demonstrated elevated serum CAs at 6 and 24 h, whereas reduced serum levels of CAs and blood regulatory T (Treg) cells at 96 h. The cytokine expression, infarct volume and neurological deficits in mouse brain were also measured. CART reduced post-stroke infarct volume and improved neurological functions, with reduced expression of inflammatory factors in the injured brain. Findings indicate that CART plays an important role in modulating post-stroke immune response and exerts a neuroprotective effect in experimental stroke. Findings also suggest that the possible mechanism of CART's protective action in stroke is the regulation of the sympathetic nervous system (SNS) pathway since CAs, Treg cells and interleukin (IL)-10 are the major modulators of SNS.
Chang
Leilei
L
Department of Neurology, Affiliated Drum Tower Hospital, Nanjing Medical University, Jiangsu, PR China.
Chen
Yanting
Y
Li
Jie
J
Liu
Zhuo
Z
Wang
Zhongyuan
Z
Chen
Junhao
J
Cao
Wangsen
W
Xu
Yun
Y
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001921:Brain / Q000276:immunology / Q000473:pathology; D002545:Brain Ischemia / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D002395:Catecholamines / Q000097:blood; D004797:Enzyme-Linked Immunosorbent Assay; D005434:Flow Cytometry; D007111:Immunity, Cellular / Q000187:drug effects; D020244:Infarction, Middle Cerebral Artery / Q000188:drug therapy / Q000473:pathology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009419:Nerve Tissue Proteins / Q000494:pharmacology*; D018696:Neuroprotective Agents; D012313:RNA / Q000096:biosynthesis / Q000302:isolation & purification; D013154:Spleen / Q000166:cytology / Q000187:drug effects / Q000276:immunology; D020521:Stroke / Q000188:drug therapy* / Q000276:immunology* / Q000473:pathology; D013601:T-Lymphocytes / Q000276:immunology; D000098882:Cocaine- and Amphetamine-Regulated Transcript Protein
D002395:Catecholamines; D009419:Nerve Tissue Proteins; D018696:Neuroprotective Agents; D000098882:Cocaine- and Amphetamine-Regulated Transcript Protein; D012313:RNA